Brief: Senzime Q2 Adjusted Gross Margin 63.3%
26/08/2024 07:00
Aug 26 (Reuters) - Senzime Q2 sales SEK 14.917 million. * Q2 EPS SEK -0.28
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona